136 related articles for article (PubMed ID: 20558317)
1. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.
Trembley JH; Wang G; Unger G; Slaton J; Ahmed K
Cell Mol Life Sci; 2009 Jun; 66(11-12):1858-67. PubMed ID: 19387548
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cancer progression by CK2: an emerging therapeutic target.
Hussain S; Guo Y; Huo Y; Shi J; Hou Y
Med Oncol; 2024 Mar; 41(5):94. PubMed ID: 38526625
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase CK2 in health and disease: CK2 and its role in Wnt and NF-kappaB signaling: linking development and cancer.
Dominguez I; Sonenshein GE; Seldin DC
Cell Mol Life Sci; 2009 Jun; 66(11-12):1850-7. PubMed ID: 19387549
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival.
St-Denis NA; Litchfield DW
Cell Mol Life Sci; 2009 Jun; 66(11-12):1817-29. PubMed ID: 19387552
[TBL] [Abstract][Full Text] [Related]
6. Casein kinase 2 phosphorylates and induces the SALL2 tumor suppressor degradation in colon cancer cells.
Hermosilla VE; Gyenis L; Rabalski AJ; Armijo ME; Sepúlveda P; Duprat F; Benítez-Riquelme D; Fuentes-Villalobos F; Quiroz A; Hepp MI; Farkas C; Mastel M; González-Chavarría I; Jackstadt R; Litchfield DW; Castro AF; Pincheira R
Cell Death Dis; 2024 Mar; 15(3):223. PubMed ID: 38493149
[TBL] [Abstract][Full Text] [Related]
7. Kinase CK2 inhibition: an update.
Cozza G; Pinna LA; Moro S
Curr Med Chem; 2013; 20(5):671-93. PubMed ID: 23210774
[TBL] [Abstract][Full Text] [Related]
8. The dark side of protein kinase CK2 inhibition.
Cozza G; Meggio F; Moro S
Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase CK2 inhibitors: a patent review.
Cozza G; Pinna LA; Moro S
Expert Opin Ther Pat; 2012 Sep; 22(9):1081-97. PubMed ID: 22908959
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase CK2 ("casein kinase-2") and its implication in cell division and proliferation.
Pinna LA; Meggio F
Prog Cell Cycle Res; 1997; 3():77-97. PubMed ID: 9552408
[TBL] [Abstract][Full Text] [Related]
11. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation.
Trembley JH; Unger GM; Gomez OC; Abedin J; Korman VL; Vogel RI; Niehans G; Kren BT; Ahmed K
Mol Cell Pharmacol; 2014; 6(2):15-25. PubMed ID: 25893034
[TBL] [Abstract][Full Text] [Related]
12. Casein kinase: the triple meaning of a misnomer.
Venerando A; Ruzzene M; Pinna LA
Biochem J; 2014 Jun; 460(2):141-56. PubMed ID: 24825444
[TBL] [Abstract][Full Text] [Related]
13. Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
Agarwal M; Nitta RT; Li G
J Mol Genet Med; 2013 Dec; 8(1):. PubMed ID: 25264454
[TBL] [Abstract][Full Text] [Related]
14. [Casein kinase 2, the versatile regulator of cell survival].
Volodina IuL; Shtil' AA
Mol Biol (Mosk); 2012; 46(3):423-33. PubMed ID: 22888632
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase CK2 and angiogenesis.
Montenarh M
Adv Clin Exp Med; 2014; 23(2):153-8. PubMed ID: 24913104
[TBL] [Abstract][Full Text] [Related]
16. The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies.
Chon HJ; Bae KJ; Lee Y; Kim J
Front Pharmacol; 2015; 6():70. PubMed ID: 25873900
[TBL] [Abstract][Full Text] [Related]
17. Mining CK2 in cancer.
Ortega CE; Seidner Y; Dominguez I
PLoS One; 2014; 9(12):e115609. PubMed ID: 25541719
[TBL] [Abstract][Full Text] [Related]
18. Targeting protein kinase CK2 suppresses prosurvival signaling pathways and growth of glioblastoma.
Zheng Y; McFarland BC; Drygin D; Yu H; Bellis SL; Kim H; Bredel M; Benveniste EN
Clin Cancer Res; 2013 Dec; 19(23):6484-94. PubMed ID: 24036851
[TBL] [Abstract][Full Text] [Related]
19. CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
Siddiqui-Jain A; Drygin D; Streiner N; Chua P; Pierre F; O'Brien SE; Bliesath J; Omori M; Huser N; Ho C; Proffitt C; Schwaebe MK; Ryckman DM; Rice WG; Anderes K
Cancer Res; 2010 Dec; 70(24):10288-98. PubMed ID: 21159648
[TBL] [Abstract][Full Text] [Related]
20. ATP site-directed inhibitors of protein kinase CK2: an update.
Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
